Viewing Study NCT00782756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-04-09 @ 1:49 PM
Study NCT ID: NCT00782756
Status: COMPLETED
Last Update Posted: 2018-02-06
First Post: 2008-10-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Cancer View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radiation View
None BEVACIZUMAB View
None AVASTIN View
None TEMOZOLOMIDE View
None newly diagnosed View
None Glioblastoma View
None GBM View
None malignant glioma View
None Radiotherapy View
None 08-126 View